Dyne Therapeutics (DYN) Competitor Comparison
We are evaluating the key criteria listed to compare Dyne Therapeutics (DYN) against its competitors in the Biotechnology industry.
Market Capitalization
82 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
289 / 337Free Cashflow
296 / 352Quick Ratio
178 / 357Earnings per Share
273 / 359Dividend yield
0 / 6Total Cash
183 / 358Performance 3 years
40 / 368Performance 5 years
103 / 368Performance 10 years
85 / 368Linearity 3 years
322 / 368Linearity 5 years
232 / 368Linearity 10 years
77 / 368Total Rank
312 / 368Dividend Rank
20 / 368Valuation Rank
367 / 368Piotroski Rank
111 / 368Muliplier Rank
333 / 368Linearity 5 years - DYN ranking 232 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.